[RNAZ] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 60.80%
YoY- 22.79%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,134 -4,290 -4,671 -3,470 -5,910 -2,330 2,771 -
Tax 13,275 -664 -36 -7 2,924 -30 -3,126 -
NP -18,409 -3,626 -4,635 -3,463 -8,834 -2,300 5,897 -
Tax Rate - - - - - - 112.83% -
Total Cost 18,409 3,626 4,635 3,463 8,834 2,300 -5,897 -
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -1,134.84 -226.60 -289.70 -216.41 -552.15 -164.25 589.73 -
EPS Diluted -1,134.84 -223.50 -285.73 -213.45 -547.70 -159.60 589.73 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.